Prenetics Global Limited reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was USD 52.32 million compared to USD 64.72 million a year ago. Net income was USD 1.61 million compared to net loss of USD 85.74 million a year ago.

Basic earnings per share from continuing operations was USD 0.15 compared to basic loss per share from continuing operations of USD 88.05 a year ago. Diluted earnings per share from continuing operations was USD 0.15 compared to diluted loss per share from continuing operations of USD 88.05 a year ago.